ID   MYLK4_HUMAN             Reviewed;         388 AA.
AC   Q86YV6; A2RUC0; Q5TAW2;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   15-MAR-2017, entry version 109.
DE   RecName: Full=Myosin light chain kinase family member 4;
DE            EC=2.7.11.1;
DE   AltName: Full=Sugen kinase 85;
DE            Short=SgK085;
GN   Name=MYLK4; Synonyms=SGK085;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-50.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 234-388 (ISOFORM 2).
RC   TISSUE=Spleen;
RA   Jikuya H., Takano J., Nomura N., Kikuno R., Nagase T., Ohara O.;
RT   "The nucleotide sequence of a long cDNA clone isolated from human
RT   spleen.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=12471243; DOI=10.1126/science.1075762;
RA   Manning G., Whyte D.B., Martinez R., Hunter T., Sudarsanam S.;
RT   "The protein kinase complement of the human genome.";
RL   Science 298:1912-1934(2002).
RN   [5]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-30; ARG-50; SER-78; MET-126;
RP   LEU-217; TYR-318 AND ARG-373.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q86YV6-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q86YV6-2; Sequence=VSP_026948;
CC         Note=Sequence incomplete. No experimental confirmation
CC         available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL138876; CAI12221.2; -; Genomic_DNA.
DR   EMBL; AL139092; CAI12221.2; JOINED; Genomic_DNA.
DR   EMBL; BC132831; AAI32832.1; -; mRNA.
DR   EMBL; BC132833; AAI32834.1; -; mRNA.
DR   EMBL; AK122581; BAC56922.1; -; mRNA.
DR   CCDS; CCDS34330.1; -. [Q86YV6-1]
DR   RefSeq; NP_001012418.2; NM_001012418.4. [Q86YV6-1]
DR   RefSeq; NP_001334801.1; NM_001347872.1.
DR   RefSeq; XP_005249136.1; XM_005249079.2. [Q86YV6-1]
DR   RefSeq; XP_016866308.1; XM_017010819.1. [Q86YV6-1]
DR   UniGene; Hs.127830; -.
DR   PDB; 2X4F; X-ray; 2.67 A; A/B=40-388.
DR   PDBsum; 2X4F; -.
DR   ProteinModelPortal; Q86YV6; -.
DR   SMR; Q86YV6; -.
DR   BioGrid; 131005; 8.
DR   IntAct; Q86YV6; 2.
DR   STRING; 9606.ENSP00000274643; -.
DR   BindingDB; Q86YV6; -.
DR   ChEMBL; CHEMBL5426; -.
DR   GuidetoPHARMACOLOGY; 2111; -.
DR   PhosphoSitePlus; Q86YV6; -.
DR   BioMuta; MYLK4; -.
DR   DMDM; 118573873; -.
DR   MaxQB; Q86YV6; -.
DR   PaxDb; Q86YV6; -.
DR   PeptideAtlas; Q86YV6; -.
DR   PRIDE; Q86YV6; -.
DR   Ensembl; ENST00000274643; ENSP00000274643; ENSG00000145949. [Q86YV6-1]
DR   GeneID; 340156; -.
DR   KEGG; hsa:340156; -.
DR   UCSC; uc003mty.5; human. [Q86YV6-1]
DR   CTD; 340156; -.
DR   DisGeNET; 340156; -.
DR   GeneCards; MYLK4; -.
DR   H-InvDB; HIX0018128; -.
DR   HGNC; HGNC:27972; MYLK4.
DR   HPA; HPA015860; -.
DR   neXtProt; NX_Q86YV6; -.
DR   OpenTargets; ENSG00000145949; -.
DR   PharmGKB; PA162396406; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   eggNOG; ENOG410XRMJ; LUCA.
DR   GeneTree; ENSGT00760000118877; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG095569; -.
DR   InParanoid; Q86YV6; -.
DR   KO; K00907; -.
DR   OMA; FYTVSKT; -.
DR   OrthoDB; EOG091G005W; -.
DR   PhylomeDB; Q86YV6; -.
DR   TreeFam; TF314166; -.
DR   SignaLink; Q86YV6; -.
DR   EvolutionaryTrace; Q86YV6; -.
DR   GenomeRNAi; 340156; -.
DR   PRO; PR:Q86YV6; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000145949; -.
DR   CleanEx; HS_MYLK4; -.
DR   Genevisible; Q86YV6; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004687; F:myosin light chain kinase activity; IBA:GO_Central.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IBA:GO_Central.
DR   InterPro; IPR020636; Ca/CaM-dep_Ca-dep_prot_Kinase.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24347; PTHR24347; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    388       Myosin light chain kinase family member
FT                                4.
FT                                /FTId=PRO_0000261030.
FT   DOMAIN      106    361       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     112    120       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    227    227       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     135    135       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ     234    252       LCVNRDAKQIKIIDFGLAR -> QCSRFLIDTSILPLCLLN
FT                                C (in isoform 2). {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_026948.
FT   VARIANT      30     30       E -> Q (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040864.
FT   VARIANT      39     39       E -> A (in dbSNP:rs7770402).
FT                                /FTId=VAR_051650.
FT   VARIANT      50     50       G -> R (in dbSNP:rs2296356).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040865.
FT   VARIANT      78     78       A -> S (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation;
FT                                dbSNP:rs762093504).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040866.
FT   VARIANT     126    126       T -> M (in dbSNP:rs34953021).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040867.
FT   VARIANT     217    217       H -> L (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040868.
FT   VARIANT     318    318       C -> Y (in dbSNP:rs35609073).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040869.
FT   VARIANT     373    373       Q -> R (in dbSNP:rs35211631).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040870.
FT   STRAND       96     98       {ECO:0000244|PDB:2X4F}.
FT   HELIX       100    102       {ECO:0000244|PDB:2X4F}.
FT   STRAND      104    111       {ECO:0000244|PDB:2X4F}.
FT   STRAND      120    125       {ECO:0000244|PDB:2X4F}.
FT   TURN        126    128       {ECO:0000244|PDB:2X4F}.
FT   STRAND      131    138       {ECO:0000244|PDB:2X4F}.
FT   HELIX       142    155       {ECO:0000244|PDB:2X4F}.
FT   STRAND      166    171       {ECO:0000244|PDB:2X4F}.
FT   STRAND      173    181       {ECO:0000244|PDB:2X4F}.
FT   HELIX       189    194       {ECO:0000244|PDB:2X4F}.
FT   HELIX       196    198       {ECO:0000244|PDB:2X4F}.
FT   HELIX       201    220       {ECO:0000244|PDB:2X4F}.
FT   HELIX       230    232       {ECO:0000244|PDB:2X4F}.
FT   STRAND      233    237       {ECO:0000244|PDB:2X4F}.
FT   TURN        238    241       {ECO:0000244|PDB:2X4F}.
FT   STRAND      242    245       {ECO:0000244|PDB:2X4F}.
FT   HELIX       272    275       {ECO:0000244|PDB:2X4F}.
FT   HELIX       282    298       {ECO:0000244|PDB:2X4F}.
FT   HELIX       308    317       {ECO:0000244|PDB:2X4F}.
FT   HELIX       325    327       {ECO:0000244|PDB:2X4F}.
FT   HELIX       332    339       {ECO:0000244|PDB:2X4F}.
FT   HELIX       346    348       {ECO:0000244|PDB:2X4F}.
FT   HELIX       352    357       {ECO:0000244|PDB:2X4F}.
FT   HELIX       359    362       {ECO:0000244|PDB:2X4F}.
FT   HELIX       364    372       {ECO:0000244|PDB:2X4F}.
SQ   SEQUENCE   388 AA;  44508 MW;  EF710F6145DFC3C9 CRC64;
     MLKVKRLEEF NTCYNSNQLE KMAFFQCREE VEKVKCFLEK NSGDQDSRSG HNEAKEVWSN
     ADLTERMPVK SKRTSALAVD IPAPPAPFDH RIVTAKQGAV NSFYTVSKTE ILGGGRFGQV
     HKCEETATGL KLAAKIIKTR GMKDKEEVKN EISVMNQLDH ANLIQLYDAF ESKNDIVLVM
     EYVDGGELFD RIIDESYNLT ELDTILFMKQ ICEGIRHMHQ MYILHLDLKP ENILCVNRDA
     KQIKIIDFGL ARRYKPREKL KVNFGTPEFL APEVVNYDFV SFPTDMWSVG VIAYMLLSGL
     SPFLGDNDAE TLNNILACRW DLEDEEFQDI SEEAKEFISK LLIKEKSWRI SASEALKHPW
     LSDHKLHSRL NAQKKKNRGS DAQDFVTK
//
